These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37014664)

  • 1. Development of LpxH Inhibitors Chelating the Active Site Dimanganese Metal Cluster of LpxH.
    Kwak SH; Skyler Cochrane C; Cho J; Dome PA; Ennis AF; Kim JH; Zhou P; Hong J
    ChemMedChem; 2023 Jun; 18(11):e202300023. PubMed ID: 37014664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors.
    Kwak SH; Cochrane CS; Ennis AF; Lim WY; Webster CG; Cho J; Fenton BA; Zhou P; Hong J
    Bioorg Chem; 2020 Sep; 102():104055. PubMed ID: 32663666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria.
    Zhou P; Hong J
    Acc Chem Res; 2021 Apr; 54(7):1623-1634. PubMed ID: 33720682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of the UDP-diacylglucosamine pyrophosphohydrolase LpxH inhibition by sulfonyl piperazine antibiotics.
    Cho J; Lee M; Cochrane CS; Webster CG; Fenton BA; Zhao J; Hong J; Zhou P
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4109-4116. PubMed ID: 32041866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Relationship of Sulfonyl Piperazine LpxH Inhibitors Analyzed by an LpxE-Coupled Malachite Green Assay.
    Lee M; Zhao J; Kwak SH; Cho J; Lee M; Gillespie RA; Kwon DY; Lee H; Park HJ; Wu Q; Zhou P; Hong J
    ACS Infect Dis; 2019 Apr; 5(4):641-651. PubMed ID: 30721024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of recent developments in the gram-negative bacterial UDP-2,3-diacylglucosamine hydrolase (LpxH) enzyme.
    Karthikeyan D; Kumar S; Jayaprakash NS
    Int J Biol Macromol; 2024 May; 267(Pt 2):131327. PubMed ID: 38574903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The substrate-binding cap of the UDP-diacylglucosamine pyrophosphatase LpxH is highly flexible, enabling facile substrate binding and product release.
    Bohl HO; Ieong P; Lee JK; Lee T; Kankanala J; Shi K; Demir Ö; Kurahashi K; Amaro RE; Wang Z; Aihara H
    J Biol Chem; 2018 May; 293(21):7969-7981. PubMed ID: 29626094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UDP-diacylglucosamine pyrophosphohydrolase LpxH in lipid A biosynthesis utilizes Mn2+ cluster for catalysis.
    Young HE; Donohue MP; Smirnova TI; Smirnov AI; Zhou P
    J Biol Chem; 2013 Sep; 288(38):26987-27001. PubMed ID: 23897835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the essential Haemophilus influenzae UDP-diacylglucosamine pyrophosphohydrolase LpxH in lipid A biosynthesis.
    Cho J; Lee CJ; Zhao J; Young HE; Zhou P
    Nat Microbiol; 2016 Aug; 1(11):16154. PubMed ID: 27780190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of the lipid A precursor UDP-2,3-diacylglucosamine in an Escherichia coli mutant lacking the lpxH gene.
    Babinski KJ; Kanjilal SJ; Raetz CR
    J Biol Chem; 2002 Jul; 277(29):25947-56. PubMed ID: 12000771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative route for UDP-diacylglucosamine hydrolysis in bacterial lipid A biosynthesis.
    Metzger LE; Raetz CR
    Biochemistry; 2010 Aug; 49(31):6715-26. PubMed ID: 20608695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the UDP-diacylglucosamine pyrophosphohydrase LpxH from Pseudomonas aeruginosa.
    Okada C; Wakabayashi H; Kobayashi M; Shinoda A; Tanaka I; Yao M
    Sci Rep; 2016 Sep; 6():32822. PubMed ID: 27609419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria.
    Huseby DL; Cao S; Zamaratski E; Sooriyaarachchi S; Ahmad S; Bergfors T; Krasnova L; Pelss J; Ikaunieks M; Loza E; Katkevics M; Bobileva O; Cirule H; Gukalova B; Grinberga S; Backlund M; Simoff I; Leber AT; Berruga-Fernández T; Antonov D; Konda VR; Lindström S; Olanders G; Brandt P; Baranczewski P; Vingsbo Lundberg C; Liepinsh E; Suna E; Jones TA; Mowbray SL; Hughes D; Karlén A
    Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2317274121. PubMed ID: 38579010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors.
    Benediktsdottir A; Sooriyaarachchi S; Cao S; Ottosson NE; Lindström S; Lundgren B; Kloditz K; Lola D; Bobileva O; Loza E; Hughes D; Jones TA; Mowbray SL; Zamaratski E; Sandström A; Karlén A
    Eur J Med Chem; 2024 Nov; 278():116790. PubMed ID: 39236497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of the Elusive UDP-Diacylglucosamine Hydrolase in the Lipid A Biosynthetic Pathway in Chlamydia trachomatis.
    Young HE; Zhao J; Barker JR; Guan Z; Valdivia RH; Zhou P
    mBio; 2016 Mar; 7(2):e00090. PubMed ID: 27006461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.
    Richie DL; Takeoka KT; Bojkovic J; Metzger LE; Rath CM; Sawyer WS; Wei JR; Dean CR
    PLoS One; 2016; 11(8):e0160918. PubMed ID: 27526195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.
    Veloo Y; Thahir SSA; Rajendiran S; Hock LK; Ahmad N; Muthu V; Shaharudin R
    Microbiol Spectr; 2022 Jun; 10(3):e0269421. PubMed ID: 35467407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutasynthetic Production and Antimicrobial Characterization of Darobactin Analogs.
    Böhringer N; Green R; Liu Y; Mettal U; Marner M; Modaresi SM; Jakob RP; Wuisan ZG; Maier T; Iinishi A; Hiller S; Lewis K; Schäberle TF
    Microbiol Spectr; 2021 Dec; 9(3):e0153521. PubMed ID: 34937193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Synthesis of a Gram-Negative-Active Cationic Lipopeptide Antibiotic Inspired by Primary Sequences from Underexplored Gram-Negative Bacteria.
    Sun R; You R; Yu X; Zhao D; Li L
    Org Lett; 2024 Feb; 26(7):1348-1352. PubMed ID: 38341869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.